Hepion Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Hepion Pharmaceuticals, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HEPION PHARMACEUTICALS. The owner is based in Edison, NJ.
Edison, NJ 08837
Showing of trademarks Trademarks
Trademark Classifications
Hepion Pharmaceuticals, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Hepion Pharmaceuticals, Inc. have?
Hepion Pharmaceuticals, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Hepion Pharmaceuticals, Inc. file in?
Hepion Pharmaceuticals, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hepion Pharmaceuticals, Inc.'s most well-known trademarks?
Hepion Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as HEPION PHARMACEUTICALS. These are among 2 currently registered trademarks in the portfolio.
What is Hepion Pharmaceuticals, Inc.'s trademark registration success rate?
Hepion Pharmaceuticals, Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.